Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Arlene A. Forastiere, Barbara Metch, Dorit Elisabeth Schuller et al. · Journal of Clinical Oncology · 1992 · 753 citations

Medicine, Oncology, Pharmacotherapy +13

Cancer statistics, 1992

C. C. Boring, T. S. Squires, T. Tong · CA A Cancer Journal for Clinicians · 1992 · 533 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

Arlene A. Forastiere, Darleen Shank, Donna Neuberg et al. · Cancer · 1998 · 200 citations

Medicine, Oncology, Pharmacotherapy +15